Literature DB >> 6418798

Interleukin 1-mediated induction of kappa-light chain synthesis and surface immunoglobulin expression on pre-B cells.

J G Giri, P W Kincade, S B Mizel.   

Abstract

In this study we have examined the effect of interleukin 1 (IL 1) on the maturation of normal and neoplastic pre-B cells. We have found that IL 1 can enhance the in vitro functional maturation of surface immunoglobulin negative (sIg-) pre-B cells from normal bone marrow. In addition, IL 1 specifically induced sIg expression on an established pre-B cell line, 70Z/3. These effects of IL 1 were obtained with the same concentrations of IL 1 that are effective in assays for T cell proliferation and functional activation. Previous studies by other investigators have demonstrated that LPS can also induce the expression of sIg on 70Z/3 cells. The stimulatory effect of LPS was dependent on the stimulation of kappa-light chain synthesis, the synthesis of mu-chains being constitutive. Our results indicate that IL 1 may also enhance sIg expression via the induction of kappa-light chain synthesis. The stimulatory effect of IL 1 was not due to contaminating LPS in the IL 1 preparations, because removal of the IL 1 by using specific antibodies against IL 1 and fixed Staphylococcus aureus cells resulted in the disappearance of kappa-chain inducing activity. In addition to IL 1, a pH 2-sensitive mediator(s) present in concanavalin A (Con A)-stimulated spleen cell supernatants was also shown to induce kappa-chain synthesis and the appearance of sIg on 70Z/3 cells. Removal of IL 1 or the inhibition of any contaminating LPS activity with polymyxin B did not diminish the activity of the pH 2-sensitive Con A supernatant factor(s). On the basis of our findings, we have concluded that IL 1 may enhance antibody responses by not only increasing the number of helper T cells but also by stimulating the maturation of B cell precursors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6418798

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.

Authors:  J Braun; A Saxon; R Wall; S L Morrison
Journal:  West J Med       Date:  1992-08

2.  The interleukin-1 receptor in Raji human B-lymphoma cells. Molecular characterization and evidence for receptor-mediated activation of gene expression.

Authors:  R Horuk; J A McCubrey
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

3.  Lipopolysaccharide-induced NF-kappa B activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 5'-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions.

Authors:  R E Law; J B Stimmel; M A Damore; C Carter; S Clarke; R Wall
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

4.  Characterization of immune inducer and suppressor macrophages from the normal human lung.

Authors:  M A Spiteri; L W Poulter
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

5.  Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation.

Authors:  C L Miller; A L Feldhaus; J W Rooney; L D Rhodes; C H Sibley; H Singh
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

6.  Lipopolysaccharide-unresponsive mutant pre-B-cell lines blocked in NF-kappa B activation.

Authors:  M Briskin; M Damore; R Law; G Lee; P W Kincade; C H Sibley; M Kuehl; R Wall
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

7.  In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C.

Authors:  F Shirakawa; S B Mizel
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

8.  Effect of insulin on the production and action of interleukin 1.

Authors:  Z H Feng; Y Luo; R D Wang; Z C Chen
Journal:  J Tongji Med Univ       Date:  1988

Review 9.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

10.  Interleukin 1 signaling occurs exclusively via the type I receptor.

Authors:  J E Sims; M A Gayle; J L Slack; M R Alderson; T A Bird; J G Giri; F Colotta; F Re; A Mantovani; K Shanebeck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.